Moderna, Inc. (NASDAQ:MRNA) ranks among the best biotech stocks to buy. Following solid trial results for Moderna, Inc.

The company's equity performance has been challenging throughout the year. Even after Wednesday's substantial advance, the stock remains down 37% year-to-date. Moderna's most recent quarterly report ...

The company's push deeper into a hot new technology, plus good news from a top collaborator, put the shine on its equity.

Pharmaceutical stocks gained Wednesday afternoon amid anticipation Pfizer's deal with the Trump administration could lead to more with other firms.

Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma ...

Nike trades higher after the sneaker and athletic apparel company’s quarterly earnings beat Wall Street estimates.

Moderna stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector.